Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

In hypertrophic cardiomyopathy, multimodality imaging is crucial to confirm diagnosis, assess for presence and mechanism of left ventricular outflow tract obstruction, and risk stratification for sudden cardiac death. This review will focus on the application of imaging to assess established and emerging factors to be considered in sudden cardiac death risk stratification.

Original publication

DOI

10.1161/circimaging.119.009026

Type

Journal article

Journal

Circulation. Cardiovascular imaging

Publication Date

17/02/2020

Volume

13

Addresses

Hypertrophic Cardiomyopathy Center, Heart and Vascular Institute, Cleveland Clinic, OH (A.T.-R., M.Y.D.).